Primary tabs
The list of publications is indicative and may not include all publications.
The adipokines in the pathogenesis and treatment of nonalcoholic fatty liver disease..
Hippokratia. 20(4), 259-263.
(2016).
Editorial: Vascular Calcification, Cardiovascular Risk and microRNAs..
Curr Vasc Pharmacol. 14(2), 208-10.
(2016).
The role of adipokines in ischemic stroke risk stratification..
Int J Stroke. 11(4), 389-98.
(2016).
Unresolved issues in lipid-lowering treatment..
Panminerva Med. 58(2), 191-5.
(2016).
Non-alcoholic fatty liver disease is associated with insulin resistance and lipid accumulation product in women with polycystic ovary syndrome..
Hum Reprod. 31(6), 1347-53.
(2016).
Expert consensus on the rational clinical use of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors..
Hormones (Athens). 15(1), 8-14.
(2016).
Adherence to antihyperglycemic treatment: a work in progress..
Expert Opin Pharmacother. 17(12), 1579-80.
(2016).
Comparative effects of more versus less aggressive treatment with statins on the long-term outcome of patients with acute ischemic stroke..
Atherosclerosis. 243(1), 65-70.
(2015).
Genetic, epidemiologic and clinical data strongly suggest that fasting or non-fasting triglycerides are independent cardiovascular risk factors..
Curr Med Res Opin. 31(3), 435-8.
(2015).
Cardiovascular Risk in Middle East Populations: A Call to Action..
Angiology. 66(9), 801-2.
(2015).
Herbal medicine-related hepatotoxicity..
World J Hepatol. 7(19), 2189-93.
(2015).
Papillary thyroid carcinomas in patients under 21 years of age: clinical and histologic characteristics of tumors ≤10 mm..
J Pediatr. 166(2), 451-6.e2.
(2015).
Editorial: Statins or Fibrates for the Primary Prevention of Stroke in the Elderly. Faith Makes Some Things Achievable, But Not AII..
Curr Vasc Pharmacol. 13(6), 696-8.
(2015).
Elevated diastolic but not systolic blood pressure increases mortality risk in hypertensive but not normotensive patients with acute ischemic stroke..
Am J Hypertens. 28(6), 765-71.
(2015).
Clinical controversies in lipid management..
Panminerva Med. 57(2), 65-70.
(2015).
Management of patients with hepatitis B in special populations..
World J Gastroenterol. 21(6), 1738-48.
(2015).
Effects of different classes of antihypertensive agents on the outcome of acute ischemic stroke..
J Clin Hypertens (Greenwich). 17(4), 275-80.
(2015).
Non-invasive methods for the diagnosis of nonalcoholic fatty liver disease..
World J Hepatol. 7(4), 638-48.
(2015).
Clinical relevance of clopidogrel-proton pump inhibitors interaction..
World J Gastrointest Pharmacol Ther. 6(2), 17-21.
(2015).
Cardiovascular risk across the histological spectrum and the clinical manifestations of non-alcoholic fatty liver disease: An update..
World J Gastroenterol. 21(22), 6820-34.
(2015).
Treatment options for dyslipidemia in chronic kidney disease and for protection from contrast-induced nephropathy..
Expert Rev Cardiovasc Ther. 13(9), 1059-66.
(2015).
Nonalcoholic fatty liver disease and statins..
Metabolism. 64(10), 1215-23.
(2015).
Cardiovascular effects of dipeptidyl peptidase-4 inhibitors..
Hippokratia. 19(3), 195-9.
(2015).
Pages
- « πρώτη
- ‹ προηγούμενη
- 1
- 2
- 3
- 4
- 5
- …
- επόμενη ›
- τελευταία »